Literature DB >> 18408108

Do we need treatment with tumour necrosis factor blockers for giant cell arteritis?

Carlo Salvarani, Nicolò Pipitone, Luigi Boiardi, Gene G Hunder.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18408108     DOI: 10.1136/ard.2007.086330

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  3 in total

Review 1.  [Current therapeutic options for giant cell arteritis].

Authors:  E Wipfler-Freissmuth; J Loock; F Moosig; C Dejaco; C Duftner; M Schirmer
Journal:  Z Rheumatol       Date:  2009-03       Impact factor: 1.372

2.  [Large vessel vasculitis : Giant cell arteritis and Takayasu arteritis].

Authors:  P M Villiger
Journal:  Z Rheumatol       Date:  2017-08       Impact factor: 1.372

3.  Effect of etanercept in polymyalgia rheumatica: a randomized controlled trial.

Authors:  Frederik Kreiner; Henrik Galbo
Journal:  Arthritis Res Ther       Date:  2010-09-20       Impact factor: 5.156

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.